Shumin Ma
Impact in
-
- Inflammasome and immune disorders
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
Papers in
-
- Protein Degradation and Inhibitors 7
- Ubiquitin and proteasome pathways 5
- Heat shock proteins research 2
- Receptor Mechanisms and Signaling 2
- Oncology 8
- Peptidase Inhibition and Analysis 5
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Shijun Chen (3 shared papers)Junhui Zhen (2 shared papers)Wenjun Du (2 shared papers)Le Zhang (1 shared paper)Chong Qin (10 shared papers)Zhixue Liu (4 shared papers)Xiaobo Li (1 shared paper)Siqi Zhang (9 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)Frontiers in Bioengineering and Biotechnology (1 paper)BioMed Research International (1 paper)Oxidative Medicine and Cellular Longevity (1 paper)BMC Medical Genomics (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Shumin Ma
31 papers receiving 308 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 196
- Nephrology 17
- Hepatology 17
- Immunology 47
- Physiology 10
Countries citing papers authored by Shumin Ma
This map shows the geographic impact of Shumin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shumin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shumin Ma more than expected).
Fields of papers citing papers by Shumin Ma
This network shows the impact of papers produced by Shumin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shumin Ma. The network helps show where Shumin Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Shumin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 54 | |
| 2 | 2023 | 29 | |
| 3 | 2023 | 25 | |
| 4 | 2018 | 22 | |
| 5 | 2016 | 21 | |
| 6 | 2013 | 20 | |
| 7 | 2023 | 14 | |
| 8 | 2021 | 13 | |
| 9 | 2016 | 13 | |
| 10 | 2018 | 12 | |
| 11 | 2013 | 11 | |
| 12 | 2024 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2018 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2019 | 5 | |
| 20 | 2023 | 3 |
About Shumin Ma
Shumin Ma is a scholar working on Molecular Biology, Oncology, Epidemiology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 310 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (5 papers), Peptidase Inhibition and Analysis (5 papers), Multiple Myeloma Research and Treatments (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Heat shock proteins research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Molecular Biology (196 citations), Nephrology (17 citations), Hepatology (17 citations), Immunology (47 citations) and Physiology (10 citations). Shumin Ma has collaborated with scholars based in China, United States and France. Frequent co-authors include Shijun Chen, Junhui Zhen, Wenjun Du, Le Zhang, Chong Qin, Zhixue Liu, Xiaobo Li, Siqi Zhang, Wenwen Luo and Zhaomin Zheng. Their work appears in journals such as Journal of Medicinal Chemistry, Frontiers in Bioengineering and Biotechnology, BioMed Research International, Oxidative Medicine and Cellular Longevity and BMC Medical Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.